Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Camptothecin

Catalog No. T1123Cas No. 7689-03-4
Alias NSC-100880, CPT, Campathecin, (S)-(+)-Camptothecin

Camptothecin (CPT) belongs to the alkaloid group of natural products and is a specific DNA topoisomerase I (Topo I) inhibitor (IC50=679 nM) with specificity. Camptothecin has antitumor activity and induces apoptosis.

Camptothecin

Camptothecin

Purity: 99.52%
Catalog No. T1123Alias NSC-100880, CPT, Campathecin, (S)-(+)-CamptothecinCas No. 7689-03-4
Camptothecin (CPT) belongs to the alkaloid group of natural products and is a specific DNA topoisomerase I (Topo I) inhibitor (IC50=679 nM) with specificity. Camptothecin has antitumor activity and induces apoptosis.
Pack SizePriceAvailabilityQuantity
100 mg$46In Stock
500 mg$136In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Camptothecin"

Select Batch
Purity:99.52%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Camptothecin (CPT) belongs to the alkaloid group of natural products and is a specific DNA topoisomerase I (Topo I) inhibitor (IC50=679 nM) with specificity. Camptothecin has antitumor activity and induces apoptosis.
Targets&IC50
Topo I:0.68 μM
In vitro
METHODS: Eight TNBC cell lines were treated with Camptothecin (0.1-5 µM) for 72 h. Cell viability was measured by PrestoBlue.
RESULTS: Camptothecin inhibited the cell viability of MCF7, HCC1428, HCC1419, HCC202, MDA453, MDA231, Sum149, and BT549 cells, with IC50 values of 0.089/0.448/0.067/0.481/0.058/0.040/0.065/ 0.056 µM.[1].
METHODS: Lung cancer cells H1299 and H460 were treated with Camptothecin (0.5-5 µM) for 16 h. Cell migration was detected by wound-healing assay.
RESULTS: Camptothecin inhibited the migration of H1299 and H460 cells without a dose-dependent effect. [2]
In vivo
METHODS: To assay antitumor activity in vivo, Camptothecin (0.15-1.2 mg/kg) and doxorubicin (0.25-2 mg/kg) were intravenously injected into athymic nu/n mice bearing triple-negative mammary carcinoma tumors, MDA-MB-231, every two days for four administrations.
RESULTS: A dose-dependent reduction in tumor growth was observed, with a 40.8% reduction at 0.5 mg/kg DOX + 0.3 mg/kg CPT and a 93% reduction at 1.5 mg/kg DOX + 0.9 mg/kg CPT. The highest dose tested (2 mg/kg DOX + 1.2 mg/kg CPT) completely stopped tumor growth on day 44. [3]
METHODS: To study the effects on obesity, Camptothecin (1 mg/kg, 0.1% Tween 80) was administered orally to obese mice once daily for three days.
RESULTS: Oral administration of Camptothecin increased circulating GDF15 levels in diet-induced obese (DIO) mice and genetic ob/ob mice. Consistent with the anorectic effects of GDF15, Camptothecin inhibited food intake, thereby reducing body weight, blood glucose, and liver fat content in obese mice. [4]
Kinase Assay
Topoisomerase I Cleavable Complex Assay: Topoisomerase I is isolated from calf thymus and is devoid of topoisomerase II. All reactions are carried out in 10 mL volumes of reaction buffer (50 mM Tris-HCl, pH 7.5, 100 mM KCl, 0.5 mM EDTA, and 30 pg/mL BSA) in microtiter plates. Camptothecin is dissolved in DMSO at 10 mg/mL and serially diluted in 96-well microtiter plates to which the 32P end-labeled pBR322 DNA and topoisomerase enzyme are added. The reaction mixture is incubated at room temperature for 30 min and then the reaction stopped by adding 2 mL of a mixture of sodium dodecyl sulfate and proteinase K (1.6% and 0.14 mg/mL final concentrations, respectively). The plates are heated at 50 °C for 30 min, 10 mL of standard stop mixture containing 0.45 N NaOH is added in order to generate single-stranded DNA, and the samples are electrophoresed in 1.5% agarose gels in TBE buffer. Gels are blotted on nitrocellulose paper, dried, and exposed to X-ray film. The units of cleavage are calculated from the autoradiographs and plotted against the log drug concentration. The IC50 values are then obtaine
Cell Research
Tumor cells are plated in 100 μL of medium in 96-well microtiter plates at a density of 1500 to 4000 cells per well and allowed to adhere overnight. Cells are incubated with Camptothecin for 48 hours and then with fresh medium for 48 hours. Camptothecin at each concentration is added in quadruplicate. Following a 4-hour incubation of treated cells with MTT, the reduced dye product is extracted from the cells with 0.2 mL of DMSO followed by 50 μL of Sorensen's buffer. The plates are shaken briefly, and the absorbance at 570 nm is read and quantitated. Curves are fitted to the MTT assay data using a four-parameter logistic equation.(Only for Reference)
AliasNSC-100880, CPT, Campathecin, (S)-(+)-Camptothecin
Chemical Properties
Molecular Weight348.35
FormulaC20H16N2O4
Cas No.7689-03-4
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 0.5 mg/mL (1.44 mM), Suspension. Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately.
DMSO: 3.48 mg/mL (10 mM)
Solution Preparation Table
10% DMSO+40% PEG300+5% Tween 80+45% Saline/DMSO
1mg5mg10mg50mg
1 mM2.8707 mL14.3534 mL28.7068 mL143.5338 mL
DMSO
1mg5mg10mg50mg
5 mM0.5741 mL2.8707 mL5.7414 mL28.7068 mL
10 mM0.2871 mL1.4353 mL2.8707 mL14.3534 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Camptothecin | purchase Camptothecin | Camptothecin cost | order Camptothecin | Camptothecin chemical structure | Camptothecin in vivo | Camptothecin in vitro | Camptothecin formula | Camptothecin molecular weight